Masjedi Mansoor, Zand Farid, Kazemi Asif Perviz, Hoseinipour Ali
Shiraz Anesthesiology and Critical Care Research Center, Department of Anesthesia and Critical Care Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
J Anaesthesiol Clin Pharmacol. 2014 Apr;30(2):217-21. doi: 10.4103/0970-9185.130024.
One of the complications of anesthesia induction with propofol is a substantial decrease in arterial blood pressure and heart rate (HR), which can be intensified by adding remifentanil. This study aimed to assess the prophylactic effects of two doses of ephedrine to control the hypotension and bradycardia caused by anesthesia induced with propofol and remifentanil.
A total of 150 patients candidate for short-term minor elective orthopedic and ophthalmic surgery under general anesthesia were randomized to three groups receiving normal saline, low dose ephedrine (0.07 mg/kg) or high dose ephedrine (0.15 mg/kg). Anesthesia was induced in all groups with propofol 2.5 mg/kg and remifentanil 3 μg/kg. No neuromuscular blocking agent was used. Patients' hemodynamic status was assessed in the following four steps: Immediately before, 2 min after induction of anesthesia, as well as 1 and 5 min after intubation.
A total of 143 patients consisting of 46 patients in the low dose ephedrine (0.07 mg/kg) group, 49 patients in the high dose ephedrine (0.15 mg/kg) group and 48 controls completed the trial. In all three groups, after induction of anesthesia, significant decreases occurred in the mean systolic, diastolic and mean arterial pressures, as well as in the mean HR. This decline was highest in the control group and lowest in the high dose ephedrine (0.15 mg/kg) group.
Our findings suggest that the administration of high dose ephedrine (0.15 mg/kg) may have a significant effect in preventing hypotension and bradycardia after anesthesia induction with propofol and remifentanil.
丙泊酚诱导麻醉的并发症之一是动脉血压和心率(HR)大幅下降,而瑞芬太尼会加剧这种情况。本研究旨在评估两剂麻黄碱对控制丙泊酚和瑞芬太尼诱导麻醉所致低血压和心动过缓的预防作用。
总共150例拟行全身麻醉下短期小型择期骨科和眼科手术的患者被随机分为三组,分别接受生理盐水、低剂量麻黄碱(0.07mg/kg)或高剂量麻黄碱(0.15mg/kg)。所有组均用2.5mg/kg丙泊酚和3μg/kg瑞芬太尼诱导麻醉。未使用神经肌肉阻滞剂。在以下四个阶段评估患者的血流动力学状态:麻醉诱导前即刻、麻醉诱导后2分钟以及插管后1分钟和5分钟。
总共143例患者完成了试验,其中低剂量麻黄碱(0.07mg/kg)组46例,高剂量麻黄碱(0.15mg/kg)组49例,对照组48例。在所有三组中,麻醉诱导后,平均收缩压、舒张压和平均动脉压以及平均HR均显著下降。对照组下降幅度最大,高剂量麻黄碱(0.15mg/kg)组下降幅度最小。
我们的研究结果表明,高剂量麻黄碱(0.15mg/kg)给药可能对预防丙泊酚和瑞芬太尼诱导麻醉后的低血压和心动过缓有显著效果。